ESC 365 - Effectiveness of ARNI (Angiotensin II Receptor Blocker Neprilysin Inhibitor) therapy in advanced HFrEF in reduction of severe functional mitral regurgitation

HFA Premium Access

Effectiveness of ARNI (Angiotensin II Receptor Blocker Neprilysin Inhibitor) therapy in advanced HFrEF in reduction of severe functional mitral regurgitation

Session: Poster Session 2 - Clinical Cases - Chronic Heart Failure – Treatment

Topic: Pharmacotherapy

Speaker: Doctor J. Berner (Lodz, PL)

Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Joanna Berner

Medical University of Lodz, Lodz (Poland)

0 follower

3 more presentations in this session

Successful use of ultrafiltration (UF) in patients with heart failure (HF) and diuretic resistant fluid overload - A 3 year experience in a District General Hospital

Diagnostic and therapeutic challenges limit treatment options in heart failure due to complex congenital heart disease

Speaker: Doctor M. Luknar (Bratislava, SK)

The heart- brain connection: tracking neurocognition from cardiogenic shock to heart transplantation

Speaker: Assistant Professor M. Robinson (Cleveland, US)

Access the full session

Poster Session 2 - Clinical Cases - Chronic Heart Failure – Treatment

Speakers: Doctor J. Berner, Doctor M. Luknar, Assistant Professor M. Robinson

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by